MERS infection rising in Saudi Arabia
The Saudi health ministry announced eight new deaths from the MERS virus on Sunday taking the kingdom’s death toll from the disease to 102. The number of recorded infections in the kingdom has risen to 339, it added.
Middle East Respiratory Syndrome (MERS) is viral respiratory illness first reported in Saudi Arabia in 2012. It is caused by a coronavirus called MERS-CoV. Most people who have been confirmed to have MERS-CoV infection developed severe acute respiratory illness. They had fever, cough, and shortness of breath. About half of these people died.
So far, all the cases have been linked to six countries in or near the Arabian Peninsula. No cases have been identified in the U.S. This virus has spread from ill people to others through close contact. However, the virus has not shown to spread in a sustained way in communities. The situation is still evolving.
Globally, from September 2012 to date, WHO has been informed of a total of 254 laboratory-confirmed cases of infection with MERS-CoV, including 93 deaths.
Based on the current situation and available information, WHO encourages all Member States to continue their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns.
Infection prevention and control measures are critical to prevent the possible spread of MERS-CoV in health care facilities. Health-care facilities that provide for patients suspected or confirmed to be infected with MERS-CoV infection should take appropriate measures to decrease the risk of transmission of the virus from an infected patient to other patients, health-care workers and visitors. Health care workers should be educated, trained and refreshed with skills on infection prevention and control.
It is not always possible to identify patients with MERS-CoV early because some have mild or unusual symptoms. For this reason, it is important that health-care workers apply standard precautions consistently with all patients – regardless of their diagnosis – in all work practices all the time.
Droplet precautions should be added to the standard precautions when providing care to all patients with symptoms of acute respiratory infection. Contact precautions and eye protection should be added when caring for probable or confirmed cases of MERS-CoV infection. Airborne precautions should be applied when performing aerosol generating procedures.
Patients should be managed as potentially infected when the clinical and epidemiological clues strongly suggest MERS-CoV, even if an initial test on a nasopharyngeal swab is negative. Repeat testing should be done when the initial testing is negative, preferably on specimens from the lower respiratory tract.
Source: World Health Organization, Switzerland
- « Codeine often prescribed to children in U.S. emergency rooms
- Zinc supplements boost immune system in children »
Editor Health NewsMERS infection rising in Saudi Arabia
by Editor Health News ( Author at Health Newstrack )
Posted on April 28th, 2014 at 12:14 pm.
Track Health News on: Health